GPR109A and Histone Deacetylases

This query combines two distinct molecular entities, GPR109A (a G protein-coupled receptor) and Histone Deacetylases (HDACs, a family of enzymes). Although they share common endogenous and therapeutic ligands (e.g., butyrate) and overlapping biological effects, they are separate biological targets and should be treated as such for structured data purposes. GPR109A is a cell-surface G protein-coupled receptor, while HDACs are intracellular enzymes. If structured data is needed, separate entries should be made for "Hydroxycarboxylic acid receptor 2 (GPR109A)" and "Histone deacetylase (HDAC)."

The shared effects of certain ligands (e.g., butyrate) on both GPR109A (agonist activation) and HDACs (enzyme inhibition) link these two distinct targets in some biological contexts, leading to overlapping anti-inflammatory, immune-modulatory, and anti-cancer effects. However, their intrinsic mechanisms of action are fundamentally different (receptor signaling vs. enzymatic deacetylation).